11 research outputs found

    Semidiscrete biomass dynamic modeling: an improved approach for assessing fish stock responses to pulsed harvest events

    Get PDF
    Continuous harvest over an annual period is a common assumption of continuous biomass dynamics models (CBDMs); however, fish are frequently harvested in a discrete manner. We developed semidiscrete biomass dynamics models (SDBDMs) that allow discrete harvest events and evaluated differences between CBDMs and SDBDMs using an equilibrium yield analysis with varying levels of fishing mortality (F). Equilibrium fishery yields for CBDMs and SDBDMS were similar at low fishing mortalities and diverged as F approached and exceeded maximum sustained yield (FMSY). Discrete harvest resulted in lower equilibrium yields at high levels of Frelative to continuous harvest. The effect of applying harvest continuously when it was in fact discrete was evaluated by fitting CBDMs and SDBDMs to time series data generated from a hypothetical fish stock undergoing discrete harvest and evaluating parameter estimates bias. Violating the assumption of continuous harvest resulted in biased parameter estimates for CBDM while SDBDM parameter estimates were unbiased. Biased parameter estimates resulted in biased biological reference points derived from CBDMs. Semidiscrete BDMs outperformed continuous BDMs and should be used when harvest is discrete, when the time and magnitude of harvest are known, and when F is greater than FMSY.This article is from Canadian Journal of Fisheries and Aquatic Sciences 69 (2012): 1710, doi:10.1139/f2012-084.</p

    Activity-based Discrete Event Simulation of Spatial Production Systems: application to fisheries

    No full text
    International audienceRelevant decision-making indicators and quantitative assessments are very strategic in management and production systems. In this paper, we present a modular and generic object framework using the Discrete EVent system Simulation Specification (DEVS) and the activity concept. We plan to simulate coastal fishery policies in the aim of improving harvesting and the management of fisheries. This work is a first step in employing Cellular Automata Models (CAM) with DEVS to design useful simulators in fisheries which are modelled as spatial production system

    Are stock assessment methods too complicated? A critical review central on North Sea demersal stocks.

    No full text
    This critical review argues that several methods for the estimation and prediction of numbers-at-age, fishing mortality coefficients F, and recruitment for a stock of fish are too hard to explain to customers (the fishing industry, managers, etc.) and do not pay enough attention to weaknesses in the supporting data, assumptions and theory. The review is linked to North Sea demersal stocks. First, weaknesses in the various types of data used in North Sea assessments are summarized, i.e. total landings, discards, commercial and research vessel abundance indices, age-length keys and natural mortality (M). A list of features that an ideal assessment should have is put forward as a basis for comparing different methods. The importance of independence and weighting when combining different types of data in an assessment is stressed. Assessment methods considered are Virtual Population Analysis, ad hoc tuning, extended survivors analysis (XSA), year-class curves, catch-at-age modelling, and state-space models fitted by Kalman filter or Bayesian methods. Year-class curves (not to be confused with ‘catch-curves’) are the favoured method because of their applicability to data sets separately, their visual appeal, simple statistical basis, minimal assumptions, the availability of confidence limits, and the ease with which estimates can be combined from different data sets after separate analyses. They do not estimate absolute stock numbers or F but neither do other methods unless M is accurately known, as is seldom true

    Protection of intraspecific biodiversity of exploited fishes

    No full text

    Management Science in the Control & Management of Fisheries: an Annotated Bibliography

    No full text

    Molecular genetics and the stock concept in fisheries

    No full text

    Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study)

    No full text
    BACKGROUND: Treatment with angiotensin-converting-enzyme (ACE) inhibitors reduces the rate of cardiovascular events among patients with left-ventricular dysfunction and those at high risk of such events. We assessed whether the ACE inhibitor perindopril reduced cardiovascular risk in a low-risk population with stable coronary heart disease and no apparent heart failure. METHODS: We recruited patients from October, 1997, to June, 2000. 13655 patients were registered with previous myocardial infarction (64%), angiographic evidence of coronary artery disease (61%), coronary revascularisation (55%), or a positive stress test only (5%). After a run-in period of 4 weeks, in which all patients received perindopril, 12218 patients were randomly assigned perindopril 8 mg once daily (n=6110), or matching placebo (n=6108). The mean follow-up was 4.2 years, and the primary endpoint was cardiovascular death, myocardial infarction, or cardiac arrest. Analysis was by intention to treat. FINDINGS: Mean age of patients was 60 years (SD 9), 85% were male, 92% were taking platelet inhibitors, 62% beta blockers, and 58% lipid-lowering therapy. 603 (10%) placebo and 488 (8%) perindopril patients experienced the primary endpoint, which yields a 20% relative risk reduction (95% CI 9-29, p=0.0003) with perindopril. These benefits were consistent in all predefined subgroups and secondary endpoints. Perindopril was well tolerated. INTERPRETATION: Among patients with stable coronary heart disease without apparent heart failure, perindopril can significantly improve outcome. About 50 patients need to be treated for a period of 4 years to prevent one major cardiovascular event. Treatment with perindopril, on top of other preventive medications, should be considered in all patients with coronary heart disease
    corecore